Market Research Report
North America Wound Management Devices Market By Product, By Application, By End User, By Country, Industry Analysis and Forecast, 2020 - 2026
|North America Wound Management Devices Market By Product, By Application, By End User, By Country, Industry Analysis and Forecast, 2020 - 2026|
Published: July 31, 2020
Content info: 87 Pages
Delivery time: 1-2 business days
North America Wound Management Devices Market By Product (Therapy Devices, Wound closure Devices and Other Products), By Application (Burns, Pressure Ulcers, Diabetic Foot Ulcers, Surgical Wounds and Other Applications), By End User (Clinics, Hospitals and Other End User), By Country, Industry Analysis and Forecast, 2020 - 2026.
The North America Wound Management Devices Market would witness market growth of 6.5% CAGR during the forecast period (2020-2026).
The introduction of new Keratin-based wound care products has made significant contributions to wound care management treatment. Keratin proteins introduced from the keratinocytes are one of the most important components used in many cellular functions. Many countries including Australia and New Zealand prefer to use Keratin-based products. There are various benefits of using keratin-based hydrogel products. These products are mostly treated on chronic dry wounds, acute wounds, and for certain skin conditions to develop moisture for the dry wounds. A keratin-rich product is to build an environment for cell growth and healing of wounds.
Specialists for wound care treatment are using low-frequency ultrasonic debridement for removing unhealthy tissue, reducing bacteria, and accelerating healing. This form of technology is helping patients to have relief from the pain and discomfort that occurred due to chronic, non-healing wounds. With the use of low-frequency ultrasonic debridement patients have seen incredible progress in wound healing, mobility, pain relief, and overall quality of life.
It is examined by different researches that the developed countries' population will experience fewer effects of a chronic wound. However, in developing countries, there would be an enormous pool of patients experiencing chronic wounds such as diabetic foot ulcers, pressure ulcers, and others. Furthermore, the expansion in the number of patients experiencing surgeries all-around has led to the rise in patient population suffering from surgical wounds.
Based on Product, the market is segmented into Therapy Devices, Wound closure Devices and Other Products. Based on Application, the market is segmented into Burns, Pressure Ulcers, Diabetic Foot Ulcers, Surgical Wounds and Other Applications. Based on End User, the market is segmented into Clinics, Hospitals and Other End User. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Coloplast Group, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson and Johnson, 3M Company, Medtronic PLC, Smith & Nephew PLC, Hollister, Inc., and Molnlycke Health Care AB.
By End User
Unique Offerings from KBV Research
8.70 Medtronic PLC
LIST OF FIGURES